The Democratic Republic of the Congo has 6 new cases, and Yemen 4.
In a new study in BMC Medicine, Dutch researchers report that, 12 months after illness onset, people with initially moderate to severe COVID-19 still had impaired health-related quality of life (HRQL), but the same was not true for mild COVID-19.
Nearly one third of 158 untreated COVID-19 patients experienced symptom rebound after being symptom-free for at least 2 consecutive days, finds a study of US adults published yesterday in JAMA Network Open.
Late last week, the Centers for Disease Control and Prevention (CDC) reported a further rise in US flu activity, particularly in the southeast and south central regions, along with another variant H3N2 (H3N2v) flu case, this time in a Michigan resident who had indirect exposure to swine at an agricultural fair.
A study of antibiotic consumption in European hospitals found increasing use of antibiotics reserved for the most difficult-to-treat infections, researchers reported yesterday in Eurosurveillance.
Children who had an underlying illness were at greatest risk for severe COVID-19 and death, but those who were vaccinated were fairly well protected, according to an observational study presented this week at the American Academy of Pediatrics (AAP) National Conference & Exhibition in Anaheim, California.
Uganda's health ministry on Twitter today reported four more lab-confirmed Ebola Sudan cases, as well as one more death in a patient with a confirmed infection. The developments push the country's overall total to 54 cases, 35 of them confirmed and 19 listed as probable. The latest death brings Uganda's fatality count to 25, 7 in confirmed patients and 18 in people who had probable infections.
The risk of a range of neurologic conditions rose significantly in the year after COVID-19 infection among a group of US veterans—regardless of whether they had required hospitalization, according to a study published yesterday in Nature Medicine.
One in three unvaccinated COVID-19 survivors in a Spanish cohort had no detectable SARS-CoV-2 antibodies nearly 1 year after infection, according to a prospective study published today in BMC Medicine.
SARS-CoV-2 antibodies fell over time after vaccination or COVID-19 infection but were restored with booster doses in West Virginia nursing home residents and staff, and antibody levels were significantly lower during the Delta than the Omicron variant surges in those with breakthrough infections, finds a study published yesterday in JAMA Network Open.